Envision Genomics has the expertise, services and resources to help solve the key bottlenecks preventing the adoption of using the genomic sequence to improve the care of patients with undiagnosed and rare disease.
Envision Genomics was founded by a pioneering group of experts in the genomics field who have successfully introduced and implemented a genomic medicine program into clinical care delivery at hospital systems. The experience and transfer of this knowledge is vital to seamlessly incorporating a genomics medicine program into your children’s hospital.
A key component to our offerings is the Codicem™ analytics software— a flexible and robust tertiary analytics platform that was developed specifically for clinical whole genome sequencing analysis, interpretation and reporting. Codicem™ was designed for diagnosing undiagnosed disease, not just recognizing known rare diseases. Codicem™ is the platform used to support Envision’s clinical analysis and interpretation services as well as is exclusively available through Envision for commercial licensing to laboratories that perform next generation sequencing analysis and interpretation in house.
Experience, expertise and excellence are the standard at Envision. As a member of the partner network, your investment gives you access to the premier technologies, processes and expertise to be a leader in genomic medicine in your market. Inquire today.